Publications by authors named "J Rumpf"

Article Synopsis
  • Inborn metabolic diseases in adults are often overlooked, particularly in routine diagnostics where suspicion is low.
  • A young patient initially diagnosed with anxiety disorder was ultimately found to have Hartnup disease after a series of unsuccessful treatments and extensive testing, which included whole-exome sequencing.
  • Following diagnosis, dietary changes and niacin supplementation led to significant improvements in the patient's condition, emphasizing the need for metabolic assessments in challenging neuropsychiatric cases.
View Article and Find Full Text PDF

Successful motor skill acquisition requires the dynamic interaction of multiple brain regions, with the striatum playing a critical role in this network. Animal studies suggest that dopaminergic mechanisms are involved in the regulation of motor learning-associated striatal plasticity. In humans, however, the contribution of nigrostriatal dopaminergic transmission to motor learning remains elusive beyond its well-characterized role in initiation and fluent execution of movements.

View Article and Find Full Text PDF

Studies on self-binding hot-pressed fiberboards using agricultural byproducts aim to identify alternatives to scarce wood resources. Particle size and mixture significantly impact strength, although direct comparisons are difficult due to differences in study methods. We evaluated fiberboards made from the two perennial biomass crops and and compared them to (spruce), using five distinct particle size blends prepared from milled and sieved particles, respectively.

View Article and Find Full Text PDF

Disease-modifying therapeutics in the α-synucleinopathies multiple system atrophy (MSA) and Parkinson's Disease (PD) are in early phases of clinical testing. Involving patients' preferences including therapy-associated risk willingness in initial stages of therapy development has been increasingly pursued in regulatory approval processes. In our study with 49 MSA and 38 PD patients, therapy-associated risk willingness was quantified using validated standard gamble scenarios for varying severities of potential drug or surgical side effects.

View Article and Find Full Text PDF

Background: Diagnostic criteria for progressive supranuclear palsy (PSP) include midbrain atrophy in MRI and hypometabolism in [F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) as supportive features. Due to limited data regarding their relative and sequential value, there is no recommendation for an algorithm to combine both modalities to increase diagnostic accuracy. This study evaluated the added value of sequential imaging using state-of-the-art methods to analyse the images regarding PSP features.

View Article and Find Full Text PDF